吲哚布芬在抗血小板治疗中的临床应用
血栓栓塞性疾病严重威胁着人类的生命健康和生活质量,而抗血小板治疗是治疗血栓栓塞性疾病的重要手段,其中吲哚布芬作为一种抗血小板药物,对于治疗及预防血栓栓塞性疾病有一定的疗效。现就吲哚布芬对高危患者血栓栓塞事件的二级预防作用及其他血栓栓塞性疾病的治疗价值,对移植血管或介入术后冠状动脉通畅性的维持作用方面做一综述,以期指导临床。...
Gespeichert in:
| Veröffentlicht in: | 中国卒中杂志 2013, Vol.8 (9), p.773-776 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | chi |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 776 |
|---|---|
| container_issue | 9 |
| container_start_page | 773 |
| container_title | 中国卒中杂志 |
| container_volume | 8 |
| creator | 吴昊 毕齐 |
| description | 血栓栓塞性疾病严重威胁着人类的生命健康和生活质量,而抗血小板治疗是治疗血栓栓塞性疾病的重要手段,其中吲哚布芬作为一种抗血小板药物,对于治疗及预防血栓栓塞性疾病有一定的疗效。现就吲哚布芬对高危患者血栓栓塞事件的二级预防作用及其他血栓栓塞性疾病的治疗价值,对移植血管或介入术后冠状动脉通畅性的维持作用方面做一综述,以期指导临床。 |
| format | Article |
| fullrecord | <record><control><sourceid>wanfang_jour_chong</sourceid><recordid>TN_cdi_wanfang_journals_zgzzzz201309022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>47272831</cqvip_id><wanfj_id>zgzzzz201309022</wanfj_id><sourcerecordid>zgzzzz201309022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c582-5d6c36a73ba5aff2dbb682856871780b2ed394f6ea3401c4c4c296dd83c12cef3</originalsourceid><addsrcrecordid>eNpjYeA0NDM31jU1NzPlYOAtLs5MMjA2MzExMjA24mQwfjph09PJs57uaH7RtebpnBXPuqa_WNjwdEP_s7n7n23a_Xza9Cc71j6f1fJkx5anu7qe7pryfMoKHgbWtMSc4lReKM3NEOLmGuLsoevj7-7p7Oijm2xqYaRrmmKWbGyWaG6clGiamJZmlJKUZGZhZGFqZmFuaG5hkGSUmmJsaZJmlppobGJgmGwChEaWZikpFsbJhkbJqWnG3AzqEGPLE_PSEvPS47PyS4vygBbGV6VXAYGRgaGxgaWBkRFQpSJEZXJGfl56YSZQbUFRZm5iUWW8ibmRuZGFsaExAMuSXpU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>吲哚布芬在抗血小板治疗中的临床应用</title><source>DOAJ Directory of Open Access Journals</source><creator>吴昊 毕齐</creator><creatorcontrib>吴昊 毕齐</creatorcontrib><description>血栓栓塞性疾病严重威胁着人类的生命健康和生活质量,而抗血小板治疗是治疗血栓栓塞性疾病的重要手段,其中吲哚布芬作为一种抗血小板药物,对于治疗及预防血栓栓塞性疾病有一定的疗效。现就吲哚布芬对高危患者血栓栓塞事件的二级预防作用及其他血栓栓塞性疾病的治疗价值,对移植血管或介入术后冠状动脉通畅性的维持作用方面做一综述,以期指导临床。</description><identifier>ISSN: 1673-5765</identifier><language>chi</language><publisher>100029,北京首都医科大学附属北京安贞医院神经内科</publisher><subject>吲哚布芬 ; 抗血小板 ; 血栓栓塞性疾病</subject><ispartof>中国卒中杂志, 2013, Vol.8 (9), p.773-776</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/88642X/88642X.jpg</thumbnail><link.rule.ids>315,781,785,4025</link.rule.ids></links><search><creatorcontrib>吴昊 毕齐</creatorcontrib><title>吲哚布芬在抗血小板治疗中的临床应用</title><title>中国卒中杂志</title><addtitle>Chinese Journal of Stroke</addtitle><description>血栓栓塞性疾病严重威胁着人类的生命健康和生活质量,而抗血小板治疗是治疗血栓栓塞性疾病的重要手段,其中吲哚布芬作为一种抗血小板药物,对于治疗及预防血栓栓塞性疾病有一定的疗效。现就吲哚布芬对高危患者血栓栓塞事件的二级预防作用及其他血栓栓塞性疾病的治疗价值,对移植血管或介入术后冠状动脉通畅性的维持作用方面做一综述,以期指导临床。</description><subject>吲哚布芬</subject><subject>抗血小板</subject><subject>血栓栓塞性疾病</subject><issn>1673-5765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0NDM31jU1NzPlYOAtLs5MMjA2MzExMjA24mQwfjph09PJs57uaH7RtebpnBXPuqa_WNjwdEP_s7n7n23a_Xza9Cc71j6f1fJkx5anu7qe7pryfMoKHgbWtMSc4lReKM3NEOLmGuLsoevj7-7p7Oijm2xqYaRrmmKWbGyWaG6clGiamJZmlJKUZGZhZGFqZmFuaG5hkGSUmmJsaZJmlppobGJgmGwChEaWZikpFsbJhkbJqWnG3AzqEGPLE_PSEvPS47PyS4vygBbGV6VXAYGRgaGxgaWBkRFQpSJEZXJGfl56YSZQbUFRZm5iUWW8ibmRuZGFsaExAMuSXpU</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>吴昊 毕齐</creator><general>100029,北京首都医科大学附属北京安贞医院神经内科</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2013</creationdate><title>吲哚布芬在抗血小板治疗中的临床应用</title><author>吴昊 毕齐</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c582-5d6c36a73ba5aff2dbb682856871780b2ed394f6ea3401c4c4c296dd83c12cef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2013</creationdate><topic>吲哚布芬</topic><topic>抗血小板</topic><topic>血栓栓塞性疾病</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>吴昊 毕齐</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>中国卒中杂志</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>吴昊 毕齐</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>吲哚布芬在抗血小板治疗中的临床应用</atitle><jtitle>中国卒中杂志</jtitle><addtitle>Chinese Journal of Stroke</addtitle><date>2013</date><risdate>2013</risdate><volume>8</volume><issue>9</issue><spage>773</spage><epage>776</epage><pages>773-776</pages><issn>1673-5765</issn><abstract>血栓栓塞性疾病严重威胁着人类的生命健康和生活质量,而抗血小板治疗是治疗血栓栓塞性疾病的重要手段,其中吲哚布芬作为一种抗血小板药物,对于治疗及预防血栓栓塞性疾病有一定的疗效。现就吲哚布芬对高危患者血栓栓塞事件的二级预防作用及其他血栓栓塞性疾病的治疗价值,对移植血管或介入术后冠状动脉通畅性的维持作用方面做一综述,以期指导临床。</abstract><pub>100029,北京首都医科大学附属北京安贞医院神经内科</pub><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1673-5765 |
| ispartof | 中国卒中杂志, 2013, Vol.8 (9), p.773-776 |
| issn | 1673-5765 |
| language | chi |
| recordid | cdi_wanfang_journals_zgzzzz201309022 |
| source | DOAJ Directory of Open Access Journals |
| subjects | 吲哚布芬 抗血小板 血栓栓塞性疾病 |
| title | 吲哚布芬在抗血小板治疗中的临床应用 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T19%3A26%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_chong&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E5%90%B2%E5%93%9A%E5%B8%83%E8%8A%AC%E5%9C%A8%E6%8A%97%E8%A1%80%E5%B0%8F%E6%9D%BF%E6%B2%BB%E7%96%97%E4%B8%AD%E7%9A%84%E4%B8%B4%E5%BA%8A%E5%BA%94%E7%94%A8&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8D%92%E4%B8%AD%E6%9D%82%E5%BF%97&rft.au=%E5%90%B4%E6%98%8A%20%E6%AF%95%E9%BD%90&rft.date=2013&rft.volume=8&rft.issue=9&rft.spage=773&rft.epage=776&rft.pages=773-776&rft.issn=1673-5765&rft_id=info:doi/&rft_dat=%3Cwanfang_jour_chong%3Ezgzzzz201309022%3C/wanfang_jour_chong%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_cqvip_id=47272831&rft_wanfj_id=zgzzzz201309022&rfr_iscdi=true |